Association of selective serotonin reuptake inhibitor exposure during pregnancy with speech, scholastic, and motor disorders in offspring

JAMA Psychiatry

Volumn 73, Issue 11, 2016, Pages 1163-1170

  Brown, Alan S ^a   Gyllenberg, David ^a   Malm, Heli ^a   McKeague, Ian W ^a   Hinkka Yli Salomi, Susanna ^a   Artama, Miia ^a   Gissler, Mika ^a   Cheslack Postava, Keely ^a   Weissman, Myrna M ^a   Gingrich, Jay A ^a   Sourander, Andre ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; EDUCATION; FEMALE; FINLAND; HUMAN; LANGUAGE DISABILITY; MALE; MENTAL DISEASE; MOTOR DYSFUNCTION; PREGNANCY; PREGNANT WOMAN; PRENATAL EXPOSURE; PROGENY; PUERPERAL DEPRESSION; SPEECH DISORDER; CASE CONTROL STUDY; CHEMICALLY INDUCED; COHORT ANALYSIS; DEPRESSIVE DISORDER; LANGUAGE DEVELOPMENT DISORDERS; LEARNING DISORDERS; MOTOR DISORDERS; PREGNANCY COMPLICATIONS; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PSYCHOLOGY; RISK; SPEECH DISORDERS;

ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEPRESSIVE DISORDER; FEMALE; FINLAND; HUMANS; LANGUAGE DEVELOPMENT DISORDERS; LEARNING DISORDERS; MALE; MOTOR DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; SEROTONIN UPTAKE INHIBITORS; SPEECH DISORDERS;

EID: 84997637275     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2016.2594     Document Type: Article

References (26)

1. Malm H, Artama M, Brown AS, et al. Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI). BMC Psychiatry. 2012;12:217.
2. CooperWO, Willy ME, Pont SJ, RayWA. Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol. 2007;196(6):544.e1-544.e5.
3. Rampono J, Simmer K, Ilett KF, et al. Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry. 2009; 42(3):95-100.
4. Boukhris T, Sheehy O, Mottron L, Bard A. Antidepressant use during pregnancy and the risk of autism spectrum disorder in children. JAMA Pediatr. 2016;170(2):117-124.
5. Croen LA, Grether JK, Yoshida CK, Odouli R, Hendrick V. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry. 2011;68(11):1104-1112.
6. Rai D, Lee BK, Dalman C, Golding J, Lewis G, Magnusson C. Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ. 2013;346:f2059.
7. Hviid A, Melbye M, Pasternak B. Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. N Engl J Med. 2013;369(25): 2406-2415.
8. Sensen MJ, Grborg TK, Christensen J, et al. Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clin Epidemiol. 2013;5: 449-459.
9. Malm H, Sourander A, Gissler M, et al. Pregnancy complications following prenatal exposure to SSRIs or maternal psychiatric disorders: results from population-based national register data. Am J Psychiatry. 2015;172(12):1224-1232.
10. Morelli E, Moore H, Rebello TJ, et al. Chronic 5-HT transporter blockade reduces DA signaling to elicit basal ganglia dysfunction. J Neurosci. 2011;31 (44):15742-15750.
11. Rebello TJ, Yu Q, Goodfellow NM, et al. Postnatal day 2 to 11 constitutes a 5-HT-sensitive period impacting adult mPFC function. J Neurosci. 2014;34(37):12379-12393.
12. Schulte EE. Learning disorders: how pediatricians can help. Cleve Clin J Med. 2015;82(11 suppl 1):S24-S28.
13. Casper RC, Gilles AA, Fleisher BE, Baran J, Enns G, Lazzeroni LC. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development. Psychopharmacology (Berl). 2011;217(2):211-219.
14. Simon GE, Cunningham ML, Davis RL. Outcomes of prenatal antidepressant exposure. Am J Psychiatry. 2002;159(12):2055-2061.
15. Casper RC, Fleisher BE, Lee-Ancajas JC, et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr. 2003;142(4):402-408.
16. Suri R, Lin AS, Cohen LS, Altshuler LL. Acute and long-Term behavioral outcome of infants and children exposed in utero to either maternal depression or antidepressants: A review of the literature. J Clin Psychiatry. 2014;75(10):e1142-e1152.
17. Nulman I, Koren G, Rovet J, et al. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry. 2012;169(11):1165-1174.
18. Weikum WM, Mayes LC, Grunau RE, Brain U, Oberlander TF. The impact of prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and maternal mood on mother-infant interactions at 3 months of age. Infant Behav Dev. 2013;36 (4):485-493.
19. Johnson KC, LaPrairie JL, Brennan PA, Stowe ZN, Newport DJ. Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry. 2012;69(8):787-794.
20. Pedersen LH, Henriksen TB, Olsen J. Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age. Pediatrics. 2010;125(3):e600-e608.
21. Weikum WM, Oberlander TF, Hensch TK, Werker JF. Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception. Proc Natl Acad Sci U S A. 2012;109(suppl 2):17221-17227.
22. Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295(5): 499-507.
23. Malm H, Brown AS, Gissler M, et al. Gestational exposure to selective serotonin reuptake inhibitors and offspring psychiatric disorders: A national register-based study. J AmAcad Child Adolesc Psychiatry. 2016;55(5):359-366.
24. Stephansson O, Granath F, Svensson T, Haglund B, Ekbom A, Kieler H. Drug use during pregnancy in Sweden: Assessed by the Prescribed Drug Register and the Medical Birth Register. Clin Epidemiol. 2011;3:43-50.
25. Steer CD, Bolton P, Golding J. Preconception and prenatal environmental factors associated with communication impairments in 9 year old children using an exposome-wide approach. PLoS One. 2015;10(3):e0118701.
26. Graham SA, Fisher SE. Decoding the genetics of speech and language. Curr Opin Neurobiol. 2013; 23(1):43-